Di Shen

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Metastatic Breast Cancer

Epidermal Growth Factor Receptor

Hepatitis C Virus

Top Venues

Cancer management and research

Journal of oncology

Journal of hepatocellular carcinoma

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Han-Bing Li, Di Wang, Yue Zhang, Di Shen, Yi-Qun Che
IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL. Journal of oncology 2023 (2023)
Han-Bing Li, Di Wang, Yue Zhang, Di Shen, Yi-Qun Che
IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL. Journal of oncology 2023 (2023)
Yi-Qun Che, Yue Zhang, Han-Bing Li, Di Shen, Wei Cui
Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring. Journal of hepatocellular carcinoma 8 (2021)
Li-Yan Qiao, Han-Bing Li, Yue Zhang, Di Shen, Peng Liu, Yi-Qun Che
CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance. Pharmacogenomics and personalized medicine 14 (2021)
Yi-Qun Che, Yue Zhang, Kai-Ping Ou, Di Wang, Di Shen, Hui-Ying Liu, Yang Luo
Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab. Cancer management and research 12 (2020)
Yang Luo, Yue Zhang, Di Wang, Di Shen, Yi-Qun Che
Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection - A Real-World Cohort Study. Cancer management and research 12 (2020)
Yi-Qun Che, Yue Zhang, Di Wang, Hui-Ying Liu, Di Shen, Yang Luo
Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab. Drug design, development and therapy 13 (2019)